Experiences with
Imjudo3 public posts
Corporate Sponsor Desires Your Feedback
They are developing a printable [i]cheat sheet[/i] for newly diagnosed HCC patients who are considering IMFINZI (durvalumab) and IMJUDO (tremelimumab) as treatment options. The goal would be to bring the cheat sheet to their doctor's appointment.
[u]Here's what they would like to know.[/u]
1.
Are you taking tremelimumab + durvalumab (Imjudo + Imfinzi)?
The American Association for Cancer Research (AACR) is seeking an HCC patient who is currently taking or has taken the combination therapy: tremelimumab + durvalumab ( + Imfinzi).
AACR would like to conduct a video interview for their annual Cancer Progress Report.
FDA Approves Imjudo and Imfinzi in Combination with Chemotherapy for Patients with NSCLC
Additionally, patients receiving Imjudo, Imfizni and chemotherapy were more likely to respond to treatment.
The new approval gives patients new immunotherapy options.
Want to take advantage of all our features? Just log in!
or